Genome Editing USA Congress:
Oxford Global is proud to present its Inaugural Genome Editing USA Congress, on the 10-11 May 2017 in Boston.
Over two days our event will bring together over 200 senior level attendees from academia, research institutes and pharma companies to discuss therapeutic and drug discovery applications, as well as novel gene-editing techniques and technologies. This event provides an ideal platform to participate in formal 1-2-1 meetings and informal networking drinks with other key industry figures, as well as providing opportunities to exchange ideas with some of the most influential professionals in the field.
The conference programme will consist of 3 interactive streams covering:
To download the conference programme please click here. (Please could you link ‘click here’ to: http://www.genomeeditingusa-congress.com/download-agenda/ )Contact Danielle Dalby for further information. firstname.lastname@example.org | +44(0)1865 248455
Advances in Transgenic Technology USA Congress:
Oxford Global are proud to present our unmissable Advances in Transgenic Technology Congress, taking place on the 10-11 May 2017 in Boston.
Over 200 senior level attendees, covering the hottest topic areas. Due to an increased sophistication in new technology becoming more widely available to researchers such as CRISPR, the transgenic market has grown significantly.
To download the conference programme please click here. (Please could you link ‘click here’ to: http://www.genomeeditingusa-congress.com/request-prices-agenda-transgenic-usa/ )TContact Danielle Dalby for further information. email@example.com | +44(0)1865 248455
This summit brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions. Our co-located 5th Discovery Chemistry & Drug Design Congress provides an unprecedented opportunity to gain insights from key presenters of the computational chemistry, discovery chemistry and medicinal field.
8 interactive streams:
Free Pre-Congress Webinars
Phenotypic Screening in Drug Discovery- Novel Tools & Applications
Hosted by Paul Andrews, Director of Operations, National Phenotypic Screening Centre (NPSC), School of Life Sciences, University of Dundee
Register for Free Today
Disruptive Technologies & Artificial Intelligence in Drug Discovery
Hosted by Chris Gibson, CEO, Recursion Pharmaceuticals
Register for Free Today
For further information on the congress and the webinars, please contact Guillaume Alonso on firstname.lastname@example.org or call +44 (0) 1865 248 455.
Oxford Global is proud to present the Microbiome Discovery and Development Congress taking place on 12 – 13 June 2017 in Berlin, Germany. This exciting conference showcases world-class speakers discussing novel strategies in microbiome research, challenges of commercialising the microbiome and latest therapeutic trends.
Including 3 Interactive Streams:
View the Agenda: http://bit.ly/2hC8ICR
Free Live Webinar:
Antibiotics & the Microbiome: Protection of the Gut Microbiome from Antibiotics
Hosted by Jean de Gunzburg, CSO, Da Volterra
Register for Free Today: http://bit.ly/2gI1USa
Key words: Molecular biology, genetics, epigenetics, DNA, RNA, gene regulation, bioinformatics, computational biology, transcription
Summary of our conference
The focus of the 2017 IMB Conference is on “Gene Regulation by the Numbers: Quantitative Approaches to Study Transcription”. Our conference will explore the latest findings and technological developments in the field of gene regulation. The regulation of gene expression is a highly complex process in which numerous different factors play a role, such as signalling pathways, transcription factors and epigenetic modifications. With the recent surge in the development of omics technologies, researchers have generated vast amounts of data describing the contribution of these factors to controlling gene activity. However, interpreting, validating and integrating the data remains a major challenge. A combination of quantitative analysis and experimental research is therefore crucial to draw a complete picture of gene regulation.
The conference will address major open questions in the field that quantitative approaches will help to address, for example:
This conference will be a unique opportunity for participants to learn about the latest discoveries, talk about their own findings and initiate research partnerships. As well as scientific sessions, there will be many networking opportunities, including poster sessions, a conference dinner and an excursion to nearby Kloster Eberbach monastery. We hope that the ideas and concepts developed during the conference will result in exciting collaborations. Anyone interested is welcome to attend and can register online.
The Joint Meeting of IUFRO WP 7.03.05 and 7.03.10 brings together experts from different countries all sharing the same enthusiasm in Forest Entomology and Pathology thus advancing our science and Forest Protection. During this meeting, new and challenging ideas are being exchanged and fruitful discussions are taking place.
At the Joint Meeting of IUFRO WP 7.03.05 and 7.03.10 experts are presenting their up-to-date studies on a good number of topics, among which:
• Ecology and population dynamics of forest insects and pathogens
• Invasive forest pests
• Monitoring, surveillance methodology and management of forest pests
• Chemical ecology of forest insects
• Genetic analysis of forest insects and pathogens
IUFRO meetings are the main scientific events in the field of Forest Sciences in general. As such, these meetings bring together reputable scientists from all over the world. This Joint Meeting in particular examining forest insects and pathogens attracts scientists that are actively involved in shaping national and international policies regarding forest pests.
Oxford Global’s 4th Annual Drug Discovery USA Congress will take place on 9 – 10 October 2017 in San Diego, USA, bringing together over 250 key opinion leaders in drug discovery. This exciting conference showcases the latest technologies and approaches being utilised across Immuno-therapy, Autoimmune diseases, Neuroscience and Oncology. Further sessions consider the key updates in medicinal and computational chemistry. The two-day congress offers an interactive platform for high level discussions, ensuring valuable networking and interactive sessions.
View Agenda: http://bit.ly/1Li0Wd4
4 Interactive Streams:
Free Webinar Recording:
Advance in Fragmented-based Drug Discovery
Hosted by Vincent Stoll, Associate Director of Structural Biology, AbbVie
Download for Free: http://bit.ly/2cuVKoT
For further information regarding prices and possible discounts, please contact Guillaume Alonso on email@example.com or call +44 (0)1865 248 455.
You are cordially invited to participate in the VII International Conference on Environmental, Industrial and Applied Microbiology - BioMicroWorld2017, which will be held in Madrid (Spain) from 18 to 20 October 2017:
The BioMicroWorld Conference is a well-established forum that has brought together researchers in the applied microbiology field every two years since 2005. This forum is aimed at communicating current research priorities and progress in the fields of industrial microbiology, biotechnology, environmental sciences, food and medical microbiology and other related fields, as well as inspiring collaborations for future research. Have a look at the detailed list of topics proposed for the conference at: http://biomicroworld2017.org/topics/
- 31 May: early registration
- 27 June: abstract submission (for oral presentation)
- 20 July: abstract submission (for poster and virtual presentation)
- 5 September: late registration
- 2 November: full paper submission